Robert W. Postma

CIK: 0001827847

Transaction Breakdown

Open Market Buys (P)3 (30.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (70.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TCRT

Alaunos Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (10 total)

TCRT
Alaunos Therapeutics, Inc.
Oct 6, 2026
Award(A)
Direct
21.8K shares at avg. $0.74$16K
TCRT
Alaunos Therapeutics, Inc.
Jul 23, 2026
Award(A)
Direct
8.5K shares at avg. $1.92$16K
TCRT
Alaunos Therapeutics, Inc.
Apr 29, 2026
Award(A)
Direct
6.3K shares at avg. $2.59$16K
TCRT
Alaunos Therapeutics, Inc.
Jan 12, 2026
Award(A)
Direct
5.6K shares at avg. $2.89$16K
TCRT
Alaunos Therapeutics, Inc.
Nov 21, 2025
Award(A)
Direct
5.1K shares at avg. $3.16$16K
TCRT
Alaunos Therapeutics, Inc.
Jul 3, 2025
Award(A)
Direct
4.1K shares-
TCRT
Alaunos Therapeutics, Inc.
Jun 24, 2025
Purchase(P)
Series A-2 Convertible Preferred Stock
Indirect
600 shares at avg. $4.49-
TCRT
Alaunos Therapeutics, Inc.
Apr 13, 2025
Award(A)
Direct
20.8K shares at avg. $2.92$61K
TCRT
Alaunos Therapeutics, Inc.
Apr 11, 2025
Purchase(P)
Series A-1 Convertible Preferred Stock
Indirect
500 shares at avg. $2.76-
TCRT
Alaunos Therapeutics, Inc.
Apr 11, 2025
Purchase(P)
Series A-1 Convertible Preferred Stock
Indirect
500 shares at avg. $2.76-

		Type	Shares	Price		Ownership
Oct 6, 2026	TCRT Alaunos Therapeutics, Inc.	Award(A)	21,829	$0.74	$16,250	Direct
Jul 23, 2026	TCRT Alaunos Therapeutics, Inc.	Award(A)	8,463	$1.92	$16,249	Direct
Apr 29, 2026	TCRT Alaunos Therapeutics, Inc.	Award(A)	6,274	$2.59	$16,250	Direct
Jan 12, 2026	TCRT Alaunos Therapeutics, Inc.	Award(A)	5,622	$2.89	$16,248	Direct
Nov 21, 2025	TCRT Alaunos Therapeutics, Inc.	Award(A)	5,142	$3.16	$16,249	Direct
Jul 3, 2025	TCRT Alaunos Therapeutics, Inc.	Award(A)	4,050	-	-	Direct
Jun 24, 2025	TCRT Alaunos Therapeutics, Inc.	Purchase(P) Series A-2 Convertible Preferred Stock	600	$4.49	-	Indirect
Apr 13, 2025	TCRT Alaunos Therapeutics, Inc.	Award(A)	20,804	$2.92	$60,748	Direct
Apr 11, 2025	TCRT Alaunos Therapeutics, Inc.	Purchase(P) Series A-1 Convertible Preferred Stock	500	$2.76	-	Indirect
Apr 11, 2025	TCRT Alaunos Therapeutics, Inc.	Purchase(P) Series A-1 Convertible Preferred Stock	500	$2.76	-	Indirect

1-10 of 10 transactions

About Postma Robert W

Postma Robert W (SEC CIK 0001827847) files insider reports with the SEC as Director of Alaunos Therapeutics, Inc. (TCRT).

Signal8 holds 8 ownership filings by Postma Robert W, all Form 4s, filed between Apr 15, 2025 and Oct 8, 2026. Those filings report 10 transactions, from Apr 11, 2025 to Oct 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Postma Robert W's filings is in FORT LAUDERDALE, FL.

Recent filings by Postma Robert W

Oct 6, 2026: Grant or award of TCRT shares (Form 4, code A).
Jul 23, 2026: Grant or award of TCRT shares (Form 4, code A).
Apr 29, 2026: Grant or award of TCRT shares (Form 4, code A).
Jan 12, 2026: Grant or award of TCRT shares (Form 4, code A).
Nov 21, 2025: Grant or award of TCRT shares (Form 4, code A).

Other insiders filing for Alaunos Therapeutics, Inc. (TCRT)

Fairmount Funds Management LLC, Director
Weis Holger, CEO
Vieser Jaime, Director
Jerman Michael Allen, Director
Groenewald Ferdinand, VP, Finance
Hogue Dale Curtis Jr.

How to read Form 4 transaction codes